Cargando…
Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension
Despite the increasing trends, reports on long-term follow-up are limited on transitioning from parenteral to oral treprostinil therapy in patients with pulmonary arterial hypertension (PAH). We investigated both the effectiveness of parenteral to oral treprostinil transition and the characteristics...
Autores principales: | Maestas, Travis, Hansen, Lillian M., Vanderpool, Rebecca R., Desai, Ankit A., Airhart, Sophia, Knapp, Shannon M., Cohen, Adam, Feldman, Jeremy, Rischard, Franz P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122247/ https://www.ncbi.nlm.nih.gov/pubmed/30124133 http://dx.doi.org/10.1177/2045894018797270 |
Ejemplares similares
-
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
por: Kingrey, John F., et al.
Publicado: (2023) -
The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling
por: Vanderpool, Rebecca R., et al.
Publicado: (2023) -
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013) -
Surfing the right ventricular pressure waveform: methods to assess global, systolic and diastolic RV function from a clinical right heart catheterization
por: Vanderpool, Rebecca R., et al.
Publicado: (2020) -
Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022)